Hematology/Oncology Pharmacy Association

What Hematology/Oncology Pharmacy Association does

Hematology/Oncology Pharmacy Association (HOPA), founded in 2004 and headquartered in Milwaukee, Wisconsin, is a nonprofit professional association serving nearly 2,700 hematology/oncology pharmacy practitioners across all 50 U.S. states. HOPA's membership spans oncology pharmacists, pharmacy interns, residents, fellows, technicians, researchers, and administrators, with horizontal segmentation across career stages rather than employer size. The organization supports the specialty through four core product pillars: education (HOPA Learn LMS delivering BCOP certification prep and CE credit programs; the Core Competency Program for entry into oncology practice; and the rotating-location Annual Conference, which drew a record 1,785 registrants in 2026), peer-reviewed publication (JHOP), advocacy (Hill Day, the End Cancer Drug Shortages Coalition of 17 organizations, and a Legislative Action Center), and patient education (the Time to Talk series covering Clinical Trials, CINV, Immune Checkpoint Inhibitors, and Cellular Therapy).

HOPA monetizes through a multi-stream nonprofit revenue model: recurring membership dues (Full and Technician tiers), paid registration and sponsorship from the annual conference (11 Industry Relations Council sponsors, 27 sponsored symposia, 60 booths from 55 companies in 2025), continuing-education programming (BCOP prep/recert, self-study, journal club), HOPA Store sales, and industry partnerships (e.g., Eisai and Helsinn on the CINV toolkit). Distribution is hybrid: self-serve online via Path LMS, direct/field via the in-person conference, and channel/reseller via partnered platforms such as the CancerBuddy app with Bone Marrow & Cancer Foundation and Walgreens Specialty Pharmacy. Governance runs through a member-elected Board of Directors under Wisconsin jurisdiction, with operational staff in the 11-50 range.

Strategic positioning centers on being the dominant specialty association for hematology/oncology pharmacy, with defensive moves like the Wellness Task Force (to stem member burnout) and offensive moves including consensus-statement publications (with ACCP's PRN), coalition leadership on policy, and patient-facing digital expansion through CancerBuddy. There is no disclosed AI/ML capability; the technology stack is conventional LMS, member portal, web, and podcast publishing. Revenue is not publicly disclosed; engagement proxies (conference attendance, Hill Day participation, membership count) suggest moderate, steady growth rather than rapid expansion.

Name

Hematology/Oncology Pharmacy Association

Legal name

Hematology/Oncology Pharmacy Association

Website

https://hoparx.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Hematology/Oncology Pharmacy Association (HOPA) is a nonprofit professional association, founded in 2004 and based in Milwaukee, WI, serving nearly 2,700 hematology/oncology pharmacy practitioners across the U.S. through education, peer-reviewed publication, advocacy, and patient education programs.

Ownership category

akta.pro rank

Headquarters

HQ city

Milwaukee

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Dues: HOPA generates revenue through membership fees, with different member types including Full Membership and Technician Membership. New members may request refunds within seven days under specific circumstances.
2. Educational Programs and Conferences: Revenue from annual conference registrations, BCOP prep and recert programs, self-study courses, virtual practice management series, and other continuing education offerings providing CE and BCOP credits.
3. HOPA Store: Sale of educational materials, publications, and resources through the HOPA Store.
4. Industry Partnerships: Sponsorships and partnerships with pharmaceutical companies through the Industry Relations Council and sponsored symposia at annual conferences.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

HOPA is a nonprofit professional association supporting hematology/oncology pharmacy practitioners through continuing education, BCOP certification preparation and recertification, an annual conference, peer-reviewed publications, advocacy, and clinical practice resources. It also produces patient-facing education toolkits (Time to Talk series) and supports oncology pharmacists through member communities, research grants, and industry partnerships.

Product overview

HOPA is a professional membership association for hematology/oncology pharmacy professionals, not a product company. Its offerings center on education and training (HOPA Learn LMS, BCOP certification programs, Annual Conference), publications (JHOP journal, HOPA Now Podcast), patient education initiatives (Time to Talk campaign including Clinical Trials, CINV, Immune Checkpoint Inhibitors, Cellular Therapy toolkits), clinical resources (Pharmacist's Application to Practice series), and member communities (HOPA Central portal, Oncology SIGs). Key collaborative initiatives include the Oral Chemotherapy Collaborative, Precision Oncology Initiative, and Pharmacy Peer Network. The CancerBuddy app, developed with Bone Marrow & Cancer Foundation and Walgreens, provides patient-facing mobile resources.

Differentiator

Problem solved

Functional benefit

Brands

• HOPA Now Podcast: Podcast featuring discussions about hematology/oncology pharmacy professional and personal topics
• HOPA Learn
• HOPA Central
• JHOP: Journal of Hematology Oncology Pharmacy
• Time to Talk
• CancerBuddy
• HOPA BCOP

Products and services

• HOPA Learn Online learning management system providing continuing education, BCOP certification prep, self-study courses, updates, journal club, oncology case series, and virtual practice management courses for hematology/oncology pharmacy professionals.
• HOPA Annual Conference Annual in-person conference offering education sessions, CE credits, BCOP credits, research posters, exhibit hall, and networking for oncology pharmacy professionals.
• HOPA Central Online member community platform providing access to resources, networking, and member-only content and tools for HOPA members.
• JHOP: Journal of Hematology Oncology Pharmacy Official peer-reviewed journal of HOPA publishing research and clinical content for hematology/oncology pharmacy practice.
• HOPA Now Podcast Podcast featuring discussions on hematology/oncology pharmacy topics, professional and personal stories, and industry developments.
• BCOP Prep & Recert Board-Certified Oncology Pharmacist (BCOP) preparation and recertification programming for hematology/oncology pharmacists.
• HOPA Core Competency Program Core competency program preparing pharmacists for oncology pharmacy practice.
• CancerBuddy App Digital patient support application developed in partnership with Bone Marrow & Cancer Foundation and Walgreens Specialty Pharmacy, providing cancer patient education, community support, and oncology pharmacist resources.

Quantifiable outcome

• HOPA Annual Conference attracts 1,702-1,785 registrants from all 50 U.S. states and multiple countries
• +2 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered minor and core.

• National Kidney FoundationminorStrategic or Co-development Partner · 8 June 2026Coalition with National Kidney Foundation and 12 other pharmacy organizations calling for transition to race-free eGFR for medication-related decision-making.
• ACCP Hematology/Oncology Practice and Research Network (PRN)coreStrategic or Co-development Partner · 28 May 2025HOPA partnered with ACCP's PRN to publish first comprehensive consensus statements on average time for U.S.-based oncology pharmacist to complete common care-related tasks, published in Journal of Oncology Pharmacy Practice.
• Bone Marrow & Cancer Foundation (BMCF)coreStrategic or Co-development Partner · 7 February 2025HOPA partnered with BMCF and Walgreens Specialty Pharmacy on the CancerBuddy app to provide digital oncology pharmacy education and resources to patients navigating cancer treatment. The app provides educational content about the role of oncology pharmacists and fosters a supportive community for patients, caregivers, and survivors.
• Walgreens Specialty PharmacycoreStrategic or Co-development Partner · 7 February 2025Collaboration to provide oncology pharmacy education through CancerBuddy app and CancerBuddy Conversation video series. Walgreens contributes clinical pharmacy expertise and patient access programs.
• CMRignitecoreGTM or Marketing Partner · 4 November 2024Collaboration on 'Time to Talk Diversity in Clinical Trials' campaign to address critical need for increased diversity in cancer clinical research. CMRignite brings health equity communications expertise as a minority-owned agency.
• Cancer Support Community (CSC)minorStrategic or Co-development Partner · 7 May 2024Live video interview partnership bringing together oncology pharmacist and cancer patient perspectives for patient education.
• Pharmacy Quality Alliance (PQA)coreStrategic or Co-development Partner · 23 August 2023Three HOPA members (Emily Mackler, Ann Schwemm, Benyam Muluneh) participated in PQA convened panel of 23 national experts and patients to improve quality of care for individuals using oral anticancer medications. HOPA contributed expertise in oncology pharmacy practice.
• Stupid CancercoreStrategic or Co-development Partner · 23 May 2023Partnership to develop tools and resources for healthcare providers serving adolescent and young adult (AYA) cancer patients. HOPA members volunteer to provide insights, curate resources, and raise awareness for AYAs with cancer, especially from historically marginalized communities.
• ASTCT (American Society for Transplantation and Cellular Therapy)minorStrategic or Co-development Partner · 15 February 2023HOPA provided BCOP education sessions at the 2023 Tandem Meetings on transplantation and cellular therapy. Coverage included GVHD prophylaxis, CAR T-cell therapy, and transplant considerations for elderly patients.
• CIBMTR (Center for International Blood and Marrow Transplant Research)minorStrategic or Co-development Partner · 15 February 2023Joint meetings coverage on transplantation and cellular therapy topics including BCOP sessions on stem cell transplantation and CAR T-cell therapy.
• AVAHO (Association of Veterans Affairs Hematology/Oncology)minorStrategic or Co-development PartnerCollaboration on BCOP Preconference at AVAHO's Annual Meeting, providing Board-Certified Oncology Pharmacist continuing education credits.
• Student National Pharmaceutical Association (SNPhA)minorStrategic or Co-development PartnerPartnership on Cancer Clarity Challenge, a national competition engaging pharmacy students and oncology pharmacists to combat cancer misinformation.
• End Cancer Drug Shortages Coalition (16+ organizations)coreStrategic or Co-development PartnerMulti-year initiative with 16 other organizations establishing consensus for combating cancer drug shortages. Coalition published consensus statement outlining factors contributing to the crisis and recommending policy solutions.
• Industry Relations Council MembersminorGTM or Marketing PartnerCouncil of pharmaceutical and healthcare industry participants supporting HOPA through sponsorships, symposia, and educational support at annual conferences. 11 sponsors and 27 sponsored symposia at 2025 conference.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• American Society of Health-System Pharmacists (ASHP): ASHP is the largest U.S. pharmacy professional association with a much broader hospital/health-system scope. HOPA members typically also belong to ASHP, and ASHP competes for oncology CE/CE-accreditation reach — making it a broad incumbent in the same professional association space.
• American Pharmacists Association (APhA): APhA is the largest national pharmacy professional association with broad community, clinical, and administrative pharmacist membership. It is a broad incumbent peer competing for general pharmacist CE and advocacy attention across the same oncology pharmacist audience.

Direct peers

• Oncology Nursing Society (ONS): ONS is the professional association for oncology nurses, paralleling HOPA's mission for oncology pharmacists. Both deliver specialty certification, CE programming, clinical resources, and advocacy — and frequently collaborate on multidisciplinary oncology education.
• American Society of Clinical Oncology (ASCO): ASCO is the leading professional association for oncology physicians, mirroring HOPA's role for oncology pharmacists. Both serve multidisciplinary oncology professionals with education, advocacy, annual conferences, and clinical guidelines — making ASCO the closest functional peer in oncology specialty societies.
• American College of Clinical Pharmacy (ACCP): ACCP is the professional association for clinical pharmacists and a direct HOPA partner (HOPA/ACCP PRN joint consensus statements). It serves an overlapping clinical-pharmacy audience with similar educational, research, and advocacy programming — making it a closely comparable peer in clinical pharmacy specialty associations.
• National Association of Specialty Pharmacy (NASP): NASP represents the specialty pharmacy industry including oncology specialty pharmacy. HOPA partners with Walgreens Specialty Pharmacy, and NASP represents the broader specialty pharmacy channel where HOPA's members practice — overlapping on oncology drug delivery and patient access.
• Association of Community Cancer Centers (ACCC): ACCC serves multidisciplinary oncology care teams in community cancer centers, including pharmacists. Both organizations focus on oncology practice delivery, advocacy, and provider education — overlapping significantly on HOPA's cancer-care delivery mission.

Emerging players

• Society of Infectious Diseases Pharmacists (SIDP): SIDP is a clinical specialty pharmacy association paralleling HOPA's structure for infectious diseases pharmacists. It is a comparable small specialty pharmacy society model with similar CE, certification support, and advocacy programming — a structural peer in specialty pharmacy associations.
• American Association of Pharmaceutical Scientists (AAPS): AAPS is a pharmaceutical sciences professional association adjacent to pharmacy practice. It overlaps with HOPA members in oncology research and pharmacotherapy and represents a comparable scientific/pharmacy association model with conferences and journals.
• American Society for Transplantation and Cellular Therapy (ASTCT): ASTCT is the professional society for transplantation and cellular therapy, with which HOPA partners on Tandem Meetings BCOP education. It serves an overlapping cellular therapy/CAR-T audience and competes for educational mindshare in subspecialty oncology pharmacy topics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xx.com/hoparx
• YouTubeyoutube.com/channel/UCNtip5ccofKuBNr8x67lCqw
• Facebookfacebook.com/HOPARX
• LinkedInlinkedin.com/company/hematology-oncology-pharmacy-association-hopa
• Instagraminstagram.com/hoparx/?hl=en

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hematology/Oncology Pharmacy Association